Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 398

1.

Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.

Boccia S, Boffetta P, Brennan P, Ricciardi G, Gianfagna F, Matsuo K, van Duijn CM, Hung RJ.

Cancer Lett. 2009 Jan 8;273(1):55-61. doi: 10.1016/j.canlet.2008.07.026. Epub 2008 Sep 11.

PMID:
18789576
2.

Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.

Boccia S, Hung R, Ricciardi G, Gianfagna F, Ebert MP, Fang JY, Gao CM, Götze T, Graziano F, Lacasaña-Navarro M, Lin D, López-Carrillo L, Qiao YL, Shen H, Stolzenberg-Solomon R, Takezaki T, Weng YR, Zhang FF, van Duijn CM, Boffetta P, Taioli E.

Am J Epidemiol. 2008 Mar 1;167(5):505-16. Epub 2007 Dec 27.

PMID:
18162478
3.

Methylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysis.

Mao R, Fan Y, Jin Y, Bai J, Fu S.

J Hum Genet. 2008;53(4):340-8. doi: 10.1007/s10038-008-0262-6. Epub 2008 Mar 14.

PMID:
18340404
4.

Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.

Shen H, Spitz MR, Wang LE, Hong WK, Wei Q.

Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):397-401.

5.

Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.

Gilbody S, Lewis S, Lightfoot T.

Am J Epidemiol. 2007 Jan 1;165(1):1-13. Epub 2006 Oct 30.

PMID:
17074966
6.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population.

Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'ugo D, Magistrelli P, Villari P, Van Duijn CM, Ricciardi G.

Biomarkers. 2007 Nov-Dec;12(6):635-44.

PMID:
17972183
7.

Methylenetetrahydrofolate reductase polymorphisms and susceptibility to gastric cancer in Chinese populations: a meta-analysis.

Sun L, Sun YH, Wang B, Cao HY, Yu C.

Eur J Cancer Prev. 2008 Oct;17(5):446-52. doi: 10.1097/CEJ.0b013e328305a140.

PMID:
18714187
8.

Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.

Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY, Sun CA.

Carcinogenesis. 2006 Nov;27(11):2295-300. Epub 2006 Jun 15.

PMID:
16777985
9.

Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms.

Shi Q, Zhang Z, Li G, Pillow PC, Hernandez LM, Spitz MR, Wei Q.

Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1477-84.

10.

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.

Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.

Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.

PMID:
20135343
11.

MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women.

Gao CM, Tang JH, Cao HX, Ding JH, Wu JZ, Wang J, Liu YT, Li SP, Su P, Matsuo K, Takezaki T, Tajima K.

J Hum Genet. 2009 Jul;54(7):414-8. doi: 10.1038/jhg.2009.57. Epub 2009 Jun 26.

PMID:
19557016
12.

Diets, polymorphisms of methylenetetrahydrofolate reductase, and the susceptibility of colon cancer and rectal cancer.

Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G, Yao K.

Cancer Detect Prev. 2005;29(2):146-54.

PMID:
15829374
13.

Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.

Oh D, Kim NK, Jang MJ, Kim HC, Lee JH, Lee JA, Ahn MJ, Kim CS, Kim HS, Park S, Chio HS, Min YH; HOGS Investigators.

Anticancer Res. 2007 Sep-Oct;27(5A):3419-24.

14.

Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population.

Kim JK, Kim S, Han JH, Kim HJ, Chong SY, Hong SP, Hwang SG, Ahn JY, Cha KY, Oh D, Kim NK.

Anticancer Res. 2005 May-Jun;25(3B):2249-52.

15.

MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls.

Bai JL, Zheng MH, Xia X, Ter-Minassian M, Chen YP, Chen F.

Eur J Cancer. 2009 May;45(8):1443-9. doi: 10.1016/j.ejca.2009.01.020. Epub 2009 Feb 14.

PMID:
19223177
16.

Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China.

Shen H, Newmann AS, Hu Z, Zhang Z, Xu Y, Wang L, Hu X, Guo J, Wang X, Wei Q.

Oncol Rep. 2005 Feb;13(2):355-60.

PMID:
15643524
18.

5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.

Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1956-63. Review.

19.

[Association between genetic polymorphisms in methylentetrahydrofolate reductase and risk of lung cancer].

Zhang XM, Miao XP, Tan W, Qu SN, Sun T, Zhou YF, Lin DX.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Dec;27(6):700-3. Chinese.

PMID:
16447641
20.

Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis.

Larsson SC, Giovannucci E, Wolk A.

Gastroenterology. 2006 Oct;131(4):1271-83. Epub 2006 Aug 5.

PMID:
17030196

Supplemental Content

Support Center